Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
Systemic lupus erythematosus (SLE) is characterized by the second highest prevalence of pulmonary arterial hypertension (PAH), after systemic sclerosis, among the connective tissue diseases. SLE-associated PAH is hemodynamically defined by increased mean pulmonary artery pressure at rest (≥25 mmHg)...
Main Authors: | Tselios, Konstantinos, Gladman, Dafna D, Urowitz, Murray B |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191623/ |
Similar Items
-
Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study
by: Nikpour, Mandana, et al.
Published: (2011) -
Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus
by: Medina-Rosas, Jorge, et al.
Published: (2015) -
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Current Status and Future Direction
by: Dhala, Atiya
Published: (2012) -
Development validation and reliability of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50
by: Touma, Z, et al.
Published: (2012) -
Asymptomatic Pulmonary Hypertension in Systemic Lupus Erythematosus
by: Kamel, Shereen R., et al.
Published: (2011)